Katie Julien, MD
Family Medicine · South Jordan, UTNPI 1386691251
Payments from drug & device makers
Across 1,634 payments — averaging $4354.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3.4M
- Modernatx, Inc.$2M
- Merck$1.1M
- Seqirus USA Inc$201K
- Sanofi Pasteur Inc.$168K
- AbbVie$110K
- plus $56K from 32 others
Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 431 | $3,442,471 |
| Modernatx, Inc. | 493 | $1,997,878 |
| Merck | 114 | $1,139,184 |
| Seqirus USA Inc | 396 | $201,488 |
| Sanofi Pasteur Inc. | 28 | $168,415 |
| AbbVie(2 entities) | 81 | $110,081 |
| Biohaven Pharmaceuticals, Inc. | 20 | $48,227 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $6,329 |
| Astellas Pharma US Inc | 2 | $185 |
| AstraZeneca | 9 | $124 |
| Biocryst Pharmaceuticals, Inc. | 3 | $100 |
| Lilly USA, LLC | 6 | $93 |
| Amgen | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Novo Nordisk | 4 | $56 |
| Currax Pharmaceuticals LLC | 2 | $50 |
| Eli Lilly | 1 | $49 |
| Abbott | 2 | $42 |
| Organon | 3 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $37 |
| Boston Scientific | 2 | $36 |
| Neuronetics, Inc. | 1 | $35 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| Bayer | 2 | $31 |
| GSK | 2 | $31 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Tris Pharma Inc | 1 | $20 |
| Verona Pharma, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Corium, LLC | 1 | $20 |
| Ascensia Diabetes Care US Inc. | 1 | $18 |
| Gilead | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
How this compares
$7,115,399 in reported general payments places this provider in the 95th percentile of 928 family medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in South Jordan
- John RichardsSouth Jordan$2.8M
- Stephanie PlunkettSouth Jordan$61K
- John HemmersmeierOgden$24.9M
- Judith KirsteinWest Jordan$22.7M
- Matthew JohnstonSalt Lake City$20.9M
- Jared ProbstSalt Lake City$18.8M
- Bryce PetersonBountiful$16M
- Sarang YoonSalt Lake City$9.4M
- Michael AdamsSandy$8.1M
- Scott EricksonBountiful$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.